110 related articles for article (PubMed ID: 18248980)
1. 4-Hydroxyphenylretinamide (4HPR) derivatives regulate aromatase activity and expression in breast cancer cells.
Su B; Mershon SM; Stonerock LA; Curley RW; Brueggemeier RW
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):40-6. PubMed ID: 18248980
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.
Ciolino HP; Wang TT; Sathyamoorthy N
Br J Cancer; 2000 Aug; 83(3):333-7. PubMed ID: 10917548
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
[TBL] [Abstract][Full Text] [Related]
4. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
[TBL] [Abstract][Full Text] [Related]
5. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
6. Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition.
Su B; Diaz-Cruz ES; Landini S; Brueggemeier RW
J Med Chem; 2006 Feb; 49(4):1413-9. PubMed ID: 16480277
[TBL] [Abstract][Full Text] [Related]
7. A positive feedback pathway of estrogen biosynthesis in breast cancer cells is contained by resveratrol.
Wang Y; Ye L; Leung LK
Toxicology; 2008 Jun; 248(2-3):130-5. PubMed ID: 18462857
[TBL] [Abstract][Full Text] [Related]
8. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
Kao YC; Okubo T; Sun XZ; Chen S
Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
[TBL] [Abstract][Full Text] [Related]
9. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells.
Wang Y; Lee KW; Chan FL; Chen S; Leung LK
Toxicol Sci; 2006 Jul; 92(1):71-7. PubMed ID: 16611627
[TBL] [Abstract][Full Text] [Related]
10. Selective regulation of aromatase expression for drug discovery.
Brueggemeier RW; Su B; Darby MV; Sugimoto Y
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):207-10. PubMed ID: 19931613
[TBL] [Abstract][Full Text] [Related]
11. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production.
Andrews WJ; Winnett G; Rehman F; Shanmugasundaram P; Hagen Dv; Schrey MP
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):159-65. PubMed ID: 15862961
[TBL] [Abstract][Full Text] [Related]
13. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells.
Su B; Landini S; Davis DD; Brueggemeier RW
J Med Chem; 2007 Apr; 50(7):1635-44. PubMed ID: 17315855
[TBL] [Abstract][Full Text] [Related]
15. Porcine hypothalamic aromatase cytochrome P450: isoform characterization, sex-dependent activity, regional expression, and regulation by enzyme inhibition in neonatal boars.
Corbin CJ; Berger T; Ford JJ; Roselli CE; Sienkiewicz W; Trainor BC; Roser JF; Vidal JD; Harada N; Conley AJ
Biol Reprod; 2009 Aug; 81(2):388-95. PubMed ID: 19403926
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
17. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
18. Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells.
Łuczak MW; Jagodziński PP
Biomed Pharmacother; 2009 May; 63(4):262-6. PubMed ID: 18602794
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
20. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.
Stauffer F; Furet P; Floersheimer A; Lang M
Bioorg Med Chem Lett; 2012 Mar; 22(5):1860-3. PubMed ID: 22335894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]